257 related articles for article (PubMed ID: 33693888)
21. Defining disrupted nighttime sleep and assessing its diagnostic utility for pediatric narcolepsy type 1.
Maski K; Pizza F; Liu S; Steinhart E; Little E; Colclasure A; Diniz Behn C; Vandi S; Antelmi E; Weller E; Scammell TE; Plazzi G
Sleep; 2020 Oct; 43(10):. PubMed ID: 32253429
[TBL] [Abstract][Full Text] [Related]
22. Sleep inertia measurement with the psychomotor vigilance task in idiopathic hypersomnia.
Evangelista E; Rassu AL; Lopez R; Biagioli N; Chenini S; Barateau L; Jaussent I; Dauvilliers Y
Sleep; 2022 Jan; 45(1):. PubMed ID: 34436617
[TBL] [Abstract][Full Text] [Related]
23. Cognitive dysfunction in central disorders of hypersomnolence: A systematic review.
Filardi M; D'Anselmo A; Agnoli S; Rubaltelli E; Mastria S; Mangiaruga A; Franceschini C; Pizza F; Corazza GE; Plazzi G
Sleep Med Rev; 2021 Oct; 59():101510. PubMed ID: 34166991
[TBL] [Abstract][Full Text] [Related]
24. Comparing objective wakefulness and vigilance tests to on-the-road driving performance in narcolepsy and idiopathic hypersomnia.
Bijlenga D; Urbanus B; van der Sluiszen NNJJM; Overeem S; Ramaekers JG; Vermeeren A; Lammers GJ
J Sleep Res; 2022 Jun; 31(3):e13518. PubMed ID: 34755413
[TBL] [Abstract][Full Text] [Related]
25. Disease-specific attention impairment in disorders of chronic excessive daytime sleepiness.
Ramm M; Boentert M; Lojewsky N; Jafarpour A; Young P; Heidbreder A
Sleep Med; 2019 Jan; 53():133-140. PubMed ID: 30508781
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic hypersomnia: a homogeneous or heterogeneous disease?
Nevsimalova S; Susta M; Prihodova I; Horvat EM; Milata M; Sonka K
Sleep Med; 2021 Apr; 80():86-91. PubMed ID: 33588261
[TBL] [Abstract][Full Text] [Related]
27. Face validation and pharmacologic analysis of Sik3
Elhosainy A; Suzuki-Abe H; Kaushik MK; Kim SJ; Saitoh T; Ishikawa Y; Hotta-Hirashima N; Miyoshi C; Funato H; Yanagisawa M
Eur J Pharmacol; 2023 Sep; 954():175877. PubMed ID: 37356786
[TBL] [Abstract][Full Text] [Related]
28. Genetics and epigenetics of rare hypersomnia.
Mogavero MP; DelRosso LM; Bruni O; Salemi M; Salsone M; Novellino F; Zucconi M; Ferini Strambi L; Ferri R
Trends Genet; 2023 May; 39(5):415-429. PubMed ID: 36842900
[TBL] [Abstract][Full Text] [Related]
29. Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry.
Trotti LM; Ong JC; Plante DT; Friederich Murray C; King R; Bliwise DL
Sleep Med; 2020 Nov; 75():343-349. PubMed ID: 32950878
[TBL] [Abstract][Full Text] [Related]
30. Decreased sleep stage transition pattern complexity in narcolepsy type 1.
Ferri R; Pizza F; Vandi S; Iloti M; Plazzi G
Clin Neurophysiol; 2016 Aug; 127(8):2812-2819. PubMed ID: 27417057
[TBL] [Abstract][Full Text] [Related]
31. Measurement of symptoms in idiopathic hypersomnia: The Idiopathic Hypersomnia Severity Scale.
Dauvilliers Y; Evangelista E; Barateau L; Lopez R; Chenini S; Delbos C; Beziat S; Jaussent I
Neurology; 2019 Apr; 92(15):e1754-e1762. PubMed ID: 30867266
[TBL] [Abstract][Full Text] [Related]
32. Disorders of excessive sleepiness: narcolepsy and hypersomnia.
Manfredi RL; Brennan RW; Cadieux RJ
Semin Neurol; 1987 Sep; 7(3):250-8. PubMed ID: 3332460
[TBL] [Abstract][Full Text] [Related]
33. Distribution of HLA-DQB1 in Czech Patients with Central Hypersomnias.
Vrana M; Siffnerova V; Pecherkova P; Ratajova E; Sonka K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):89-98. PubMed ID: 28083611
[TBL] [Abstract][Full Text] [Related]
34. Narcolepsy with and without cataplexy, idiopathic hypersomnia with and without long sleep time: a cluster analysis.
Šonka K; Šusta M; Billiard M
Sleep Med; 2015 Feb; 16(2):225-31. PubMed ID: 25576137
[TBL] [Abstract][Full Text] [Related]
35. Different fates of excessive daytime sleepiness: survival analysis for remission.
Kim T; Lee JH; Lee CS; Yoon IY
Acta Neurol Scand; 2016 Jul; 134(1):35-41. PubMed ID: 26392230
[TBL] [Abstract][Full Text] [Related]
36. Actigraphy measurement of physical activity and energy expenditure in narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia: A Sensewear Armband study.
Bornstein A; Hedström A; Wasling P
J Sleep Res; 2021 Apr; 30(2):e13038. PubMed ID: 32281246
[TBL] [Abstract][Full Text] [Related]
37. Comorbidity between central disorders of hypersomnolence and immune-based disorders.
Barateau L; Lopez R; Arnulf I; Lecendreux M; Franco P; Drouot X; Leu-Semenescu S; Jaussent I; Dauvilliers Y
Neurology; 2017 Jan; 88(1):93-100. PubMed ID: 27864522
[TBL] [Abstract][Full Text] [Related]
38. Pupillometry to differentiate idiopathic hypersomnia from narcolepsy type 1.
Rach H; Reynaud E; Kilic-Huck U; Ruppert E; Comtet H; Roy de Belleplaine V; Fuchs F; Van Someren EJW; Geoffroy PA; Bourgin P
J Sleep Res; 2023 Oct; 32(5):e13885. PubMed ID: 37002816
[TBL] [Abstract][Full Text] [Related]
39. Altered Regional Cerebral Blood Flow in Idiopathic Hypersomnia.
Boucetta S; Montplaisir J; Zadra A; Lachapelle F; Soucy JP; Gravel P; Dang-Vu TT
Sleep; 2017 Oct; 40(10):. PubMed ID: 28958044
[TBL] [Abstract][Full Text] [Related]
40. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions.
Dauvilliers Y; Delallée N; Jaussent I; Scholz S; Bayard S; Croyal M; Schwartz JC; Robert P
Sleep; 2012 Oct; 35(10):1359-66. PubMed ID: 23024434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]